Prostate Cancer Clinical Trial
— VAMISOfficial title:
Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery
NCT number | NCT05279287 |
Other study ID # | TGI 001 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | February 1, 2023 |
Est. completion date | August 31, 2024 |
Despite the high volumes, advanced minimally invasive surgery is non-standardised and variations often occur in surgical technique, performance, delivery, team communication, and surgical approach. Such variations can result in errors and complications that can potentially be avoided. This project aims to analyse surgical phases (stage of the operation), skill and errors to anonymised, surgical video data through Medtronic's Touch Surgery™ Enterprise DS1 Computer which can capture video data anonymously in any minimally invasive (key hole) procedure in the operating room, allowing immediate, upload of data to a platform for immediate feedback and assessment to surgeons. The investigators hypothesise that understanding technical performance and surgical processes, may reduce unwarranted variations, errors and near misses, and improve the performance of the entire surgical team that is ultimately hoped to enhance patient safety and outcomes. Investigators plan to develop assessment tools with the hope to improve feedback, learning and ultimately surgeons' performances. The latest methodology of manual (OCHRA) and automated assessment (artificial intelligence) will be applied. Investigators aim to validate these methods by correlating video "scores" of skill/errors to patient outcomes e.g. complications, cancer outcome.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | August 31, 2024 |
Est. primary completion date | August 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient undergoing elective minimally-invasive urological/gastrointestinal surgery - 18 years old or over - Have capacity to provide informed consent Exclusion Criteria: - Surgery performed with palliative intent or under unplanned/emergency settings - Under 18 years old - Cannot consent |
Country | Name | City | State |
---|---|---|---|
United Kingdom | London North West University Healthcare NHS Trust | London | |
United Kingdom | University College London Hospitals NHS Trust | London | |
United Kingdom | Portsmouth Hospitals NHS Foundation Trust | Portsmouth | |
United Kingdom | North Tees and Hartlepool NHS Foundation Trust | Stockton-on-Tees | |
United Kingdom | Yeovil Hospital, Somerset NHS Foundation Trust | Yeovil | Somerset |
Lead Sponsor | Collaborator |
---|---|
The Griffin Institute | Medtronic, Wellcome/EPSRC for Interventional and Surgical Sciences (WEISS) |
United Kingdom,
Ahmed K, Khan R, Mottrie A, Lovegrove C, Abaza R, Ahlawat R, Ahlering T, Ahlgren G, Artibani W, Barret E, Cathelineau X, Challacombe B, Coloby P, Khan MS, Hubert J, Michel MS, Montorsi F, Murphy D, Palou J, Patel V, Piechaud PT, Van Poppel H, Rischmann P, Sanchez-Salas R, Siemer S, Stoeckle M, Stolzenburg JU, Terrier JE, Thuroff JW, Vaessen C, Van Der Poel HG, Van Cleynenbreugel B, Volpe A, Wagner C, Wiklund P, Wilson T, Wirth M, Witt J, Dasgupta P. Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts. BJU Int. 2015 Jul;116(1):93-101. doi: 10.1111/bju.12974. Epub 2015 Mar 23. — View Citation
Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991 Feb 7;324(6):370-6. doi: 10.1056/NEJM199102073240604. — View Citation
Chen J, Cheng N, Cacciamani G, Oh P, Lin-Brande M, Remulla D, Gill IS, Hung AJ. Objective Assessment of Robotic Surgical Technical Skill: A Systematic Review. J Urol. 2019 Mar;201(3):461-469. doi: 10.1016/j.juro.2018.06.078. — View Citation
Collins JW, Levy J, Stefanidis D, Gallagher A, Coleman M, Cecil T, Ericsson A, Mottrie A, Wiklund P, Ahmed K, Pratschke J, Casali G, Ghazi A, Gomez M, Hung A, Arnold A, Dunning J, Martino M, Vaz C, Friedman E, Baste JM, Bergamaschi R, Feins R, Earle D, Pusic M, Montgomery O, Pugh C, Satava RM. Utilising the Delphi Process to Develop a Proficiency-based Progression Train-the-trainer Course for Robotic Surgery Training. Eur Urol. 2019 May;75(5):775-785. doi: 10.1016/j.eururo.2018.12.044. Epub 2019 Jan 19. — View Citation
Collins JW, Wisz P. Training in robotic surgery, replicating the airline industry. How far have we come? World J Urol. 2020 Jul;38(7):1645-1651. doi: 10.1007/s00345-019-02976-4. Epub 2019 Oct 17. — View Citation
Curtis NJ, Foster JD, Miskovic D, Brown CSB, Hewett PJ, Abbott S, Hanna GB, Stevenson ARL, Francis NK. Association of Surgical Skill Assessment With Clinical Outcomes in Cancer Surgery. JAMA Surg. 2020 Jul 1;155(7):590-598. doi: 10.1001/jamasurg.2020.1004. — View Citation
Foster JD, Miskovic D, Allison AS, Conti JA, Ockrim J, Cooper EJ, Hanna GB, Francis NK. Application of objective clinical human reliability analysis (OCHRA) in assessment of technical performance in laparoscopic rectal cancer surgery. Tech Coloproctol. 2016 Jun;20(6):361-367. doi: 10.1007/s10151-016-1444-4. Epub 2016 May 6. — View Citation
Goh AC, Goldfarb DW, Sander JC, Miles BJ, Dunkin BJ. Global evaluative assessment of robotic skills: validation of a clinical assessment tool to measure robotic surgical skills. J Urol. 2012 Jan;187(1):247-52. doi: 10.1016/j.juro.2011.09.032. Epub 2011 Nov 17. — View Citation
Hanna GB, Mackenzie H, Miskovic D, Ni M, Wyles S, Aylin P, Parvaiz A, Cecil T, Gudgeon A, Griffith J, Robinson JM, Selvasekar C, Rockall T, Acheson A, Maxwell-Armstrong C, Jenkins JT, Horgan A, Cunningham C, Lindsey I, Arulampalam T, Motson RW, Francis NK, Kennedy RH, Coleman MG; on behalfofLapco program. Laparoscopic Colorectal Surgery Outcomes Improved After National Training Program (LAPCO) for Specialists in England. Ann Surg. 2022 Jun 1;275(6):1149-1155. doi: 10.1097/SLA.0000000000004584. Epub 2020 Oct 19. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of errors in an operation using validated methodology- Objective Clinical Human Reliability Analysis (OCHRA) | Objective Clinical Human Reliability Analysis (OCHRA) methodology will be applied to video visual data to assess number, type and severity of errors within the operation. | 2 years of video data will be recorded prospectively | |
Secondary | Secondary outcome measure- Age | Age (years) | Up to 5 years, the normal time period of follow-up for cancer related outcomes | |
Secondary | Secondary outcome measure- ASA grade | ASA grade I-V (internationally accepted anaesthetic risk score) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure -BMI | weight and height will be combined to report BMI in kg/m^2 | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | neoadjuvant treatment (Type-chemotherapy/radiotherapy- Yes or No | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | Total operating time (minutes) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | Operative blood loss (millilitres) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | Conversion to open surgery (binary- Yes or No) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | length of post-operative stay (days) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | 30-day readmission rate (Yes or No) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | 30 day readmission reason (aetiology) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | histolopathological outcomes (pTNM cancer staging) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | Postoperative complications using Clavien-Dindo classification (1-5 scale of severity and necessary corrective action) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | 30-day mortality (Yes or No) | Up to 2 years and 6 months, duration of the study | |
Secondary | Secondary outcome measure | All cause mortality (Yes or No) | Up to 2 years and 6 months, duration of the study | |
Secondary | Application of Machine learning and Artificial Intelligence to video analysis | Using AI and machine learning to identify surgical phases and errors based on kinematic and video data, or video data alone | Up to 2 years and 6 months, duration of the study |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |